Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL
Clinical trial NCT05626400 · RECRUITING
Trial details
- NCT number
- NCT05626400
- Sponsor
- Hebei Senlang Biotechnology Inc., Ltd.
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-29
- Primary completion
- 2027-10-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.